Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Human Hypertension|October 31, 2014
An update on the pharmacogenetics of treating hypertensionV Fontana, M R Luizon, V C SandrimBJOG : an International Journal of Obstetrics and Gynaecology|February 9, 2016
Circulating microRNA expression profiles in pre-eclampsia: evidence of increased miR-885-5p levelsV C Sandrim, M R Luizon, A C Palei, et al.Journal of Human Hypertension|December 23, 2011
Functional VEGF haplotypes affect the susceptibility to hypertensionV C Sandrim, M R Luizon, T C Izidoro-Toledo, et al.European Journal of Clinical Pharmacology|June 19, 2012
eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalaprilP S Silva, V Fontana, M R Luizon, et al.The Pharmacogenomics Journal|August 26, 2009
eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertensionV C Sandrim, A C T Palei, M R Luizon, et al.Journal of Human Hypertension|July 1, 2011
Maternal iNOS genetic polymorphisms and hypertensive disorders of pregnancyL M Amaral, A C T Palei, V C Sandrim, et al.Journal of Human Hypertension|June 20, 2014
The effects of endothelial nitric oxide synthase tagSNPs on nitrite levels and risk of hypertension and obesity in children and adolescentsJ A de Miranda, R Lacchini, V A Belo, et al.International Journal of Obesity (2005)|October 9, 2013
The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesityV A Belo, M R Luizon, R Lacchini, et al.Journal of Human Hypertension|February 11, 2011
Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patientsR Lacchini, A L B Jacob-Ferreira, M R Luizon, et al.International Journal of Obesity (2005)|August 17, 2011
Matrix metalloproteinase-9 genetic variations affect MMP-9 levels in obese childrenV A Belo, D C Souza-Costa, M R Luizon, et al.Pageof 2